Iron Studies in Sideroblastic Anemia
In sideroblastic anemia, iron studies characteristically show elevated serum ferritin and increased transferrin saturation (TSAT), reflecting systemic iron overload that occurs even before transfusion therapy begins. 1
Expected Iron Study Findings
Serum Ferritin
- Elevated ferritin levels are the hallmark finding, ranging from normal in rare early cases to markedly elevated (>2000 μg/L) in established disease 2
- Ferritin levels of 500-4000 ng/mL are commonly observed at diagnosis in untreated patients 2
- In patients receiving transfusions, ferritin can reach 4700-9500 ng/mL, indicating manifest iron overload with tissue damage 2
- Important caveat: Normal ferritin does not exclude liver iron loading in sideroblastic anemia, particularly in SLC11A2 defects, and MRI assessment should be considered 1
Transferrin Saturation (TSAT)
- Increased TSAT is a consistent finding across sideroblastic anemia subtypes 1
- TSAT >60% is highly predictive of severe iron overload (liver iron content >7 mg/g) 3
- In SLC25A38 defects specifically, TSAT is increased even before transfusion therapy begins 1
Pattern of Iron Overload
- Praelatent and latent iron overload with ferritin up to >2000 ng/mL occurs frequently at diagnosis 2
- The combination of TSAT >60% with serum ferritin >963 μg/L correctly identifies 95.3% of patients with severe liver iron overload 3
- Iron overload results from two mechanisms: ineffective erythropoiesis causing increased intestinal iron absorption, and transfusion-related iron accumulation 4
Monitoring Recommendations
Initial Assessment
- Check ferritin and TSAT to detect iron loading at diagnosis 1
- Assess liver enzymes and screen for signs of liver fibrosis or hepatocellular carcinoma 1
- Consider MRI-based liver iron quantification when ferritin is elevated but clinical significance is uncertain 1
Ongoing Surveillance
- Serial monitoring of iron parameters is essential to detect toxic iron loading early, particularly in patients receiving oral iron supplementation or transfusions 1
- Life-threatening iron overload can occur even without severe anemia in sideroblastic disorders 5
- Assessment of erythroid expansion in bone marrow aspirates may help predict the risk of iron loading 5
Clinical Implications by Subtype
X-Linked Sideroblastic Anemia (XLSA/ALAS2 defects)
- Iron parameters show loading with or without severe anemia 1
- Iron overload should be treated preferably by phlebotomies 1
SLC25A38 Defects
- Serum ferritin and TSAT are increased even before transfusion therapy 1
- Requires chelation therapy as part of symptomatic management 1
GLRX5 Defects
- Present with microcytic sideroblastic anemia and iron loading 1
- Iron loading requires chelation therapy 1
Critical pitfall: Do not assume normal ferritin excludes significant iron overload—liver MRI may be necessary to accurately assess tissue iron burden, particularly in genetic subtypes like SLC11A2 defects 1. Additionally, ineffective erythropoiesis alone (without HFE gene mutations) can lead to substantial iron overload in sideroblastic anemia patients 6.